These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25132763)

  • 1. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices.
    Di Pascoli L; Buja A; Bolognesi M; Montagnese S; Gatta A; Gregori D; Merkel C
    World J Gastroenterol; 2014 Aug; 20(30):10464-9. PubMed ID: 25132763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model.
    Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B
    Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective?
    Spiegel BM; Targownik L; Dulai GS; Karsan HA; Gralnek IM
    Hepatology; 2003 Feb; 37(2):366-77. PubMed ID: 12540787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary prophylaxis of variceal bleeding.
    Ilyas JA; Kanwal F
    Gastroenterol Clin North Am; 2014 Dec; 43(4):783-94. PubMed ID: 25440925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding.
    Imperiale TF; Klein RW; Chalasani N
    Hepatology; 2007 Apr; 45(4):870-8. PubMed ID: 17393528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The budget impact of endoscopic screening for esophageal varices in cirrhosis.
    Spiegel BM; Esrailian E; Eisen G
    Gastrointest Endosc; 2007 Oct; 66(4):679-92. PubMed ID: 17905009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis.
    Jakab SS; Garcia-Tsao G
    Clin Liver Dis; 2020 Aug; 24(3):335-350. PubMed ID: 32620275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding.
    Khuroo MS; Khuroo NS; Farahat KL; Khuroo YS; Sofi AA; Dahab ST
    Aliment Pharmacol Ther; 2005 Feb; 21(4):347-61. PubMed ID: 15709985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oesophageal varices in cirrhotic patients: from variceal screening to primary prophylaxis of the first oesophageal variceal bleeding.
    Zhang C; Thabut D; Kamath PS; Shah VH
    Liver Int; 2011 Jan; 31(1):108-19. PubMed ID: 20946450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ß-blocker therapy to prevent primary bleeding of esophageal varices.
    Tursi T
    J Am Acad Nurse Pract; 2010 Dec; 22(12):640-7. PubMed ID: 21129071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
    Arguedas MR; Heudebert GR; Eloubeidi MA; Abrams GA; Fallon MB
    Am J Gastroenterol; 2002 Sep; 97(9):2441-52. PubMed ID: 12358270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding.
    Sarin SK; Lamba GS; Kumar M; Misra A; Murthy NS
    N Engl J Med; 1999 Apr; 340(13):988-93. PubMed ID: 10099140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary prophylaxis of esophageal variceal bleeding in cirrhosis.
    Bellot P; García-Pagán JC; Abraldes JG; Bosch J
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):532-40. PubMed ID: 18456445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of treating esophageal varices.
    Talwalkar JA
    Clin Liver Dis; 2006 Aug; 10(3):679-89, xi. PubMed ID: 17162235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decision analysis of prophylactic treatment for patients with high-risk esophageal varices.
    Aoki N; Kajiyama T; Beck JR; Cone RW; Soma K; Fukui T
    Gastrointest Endosc; 2000 Dec; 52(6):707-14. PubMed ID: 11115900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
    Imperiale TF; Chalasani N; Klein RW
    Am J Gastroenterol; 2003 Dec; 98(12):2742-50. PubMed ID: 14687827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical prophylaxis of haemorrhage from oesophageal varices in patients with liver cirrhosis.
    Gross M; Zoller WG
    Eur J Gastroenterol Hepatol; 1997 Jun; 9(6):603-12. PubMed ID: 9222734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis.
    Lay CS; Tsai YT; Lee FY; Lai YL; Yu CJ; Chen CB; Peng CY
    J Gastroenterol Hepatol; 2006 Feb; 21(2):413-9. PubMed ID: 16509867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.